Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I
about
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoeaRecent advances in understanding enteric pathogenic Escherichia coli.Vaccines against enterotoxigenic Escherichia coli.A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phasMucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coliGenetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.Needle-free vaccine delivery.Crystallization and preliminary X-ray diffraction analyses of several forms of the CfaB major subunit of enterotoxigenic Escherichia coli CFA/I fimbriae.Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: oral vaccines in HIVProgress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.Construction and evaluation of a fluorescence-based live attenuated Escherichia coli delivery system for generating oral vaccine candidate.Reaching a consensus on management practices and vaccine development targets for mitigation of infectious diarrhoea among deployed US military forces.Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B.Surface display of the HPV L1 capsid protein by the autotransporter Shigella IcsA.
P2860
Q24201328-1F53211D-9D76-4D14-AEB7-CE84E5B118D9Q34375210-28EFA7AC-47EC-4BEB-8733-A6467893C9F3Q34594874-5CAD718C-F514-4F0F-B0BB-D7A63C60B73DQ35598235-5E087078-F360-43FF-BAA6-274296C49239Q35784019-D52D6C76-1228-4E33-978C-AB53EA8ADB62Q36172686-F41796EB-369F-452D-93E0-D0BC6652BC3DQ36945838-3E4A993E-20F3-444F-83E7-5A0A62817805Q37115488-901B0BCB-B93A-4C39-A5A2-6DC98EF698A7Q37187396-F90EA48E-FDED-48C4-BDD2-2BDC9403820CQ38032878-5F3A6B77-6377-4365-92DE-50589FED1504Q39063059-3D08D6A1-2F27-45F9-A2B8-9FAB50C77A08Q39397885-FF22CE65-5085-40AB-8BA8-825DA2F3CCDFQ39657777-55436A9A-6701-4DD5-AAB8-7A3F66C0E241Q42245186-345E1F34-A4BF-4B03-9D80-B6384BA0555B
P2860
Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Construction and phase I clini ...... onization factor antigen CFA/I
@ast
Construction and phase I clini ...... onization factor antigen CFA/I
@en
Construction and phase I clini ...... onization factor antigen CFA/I
@nl
type
label
Construction and phase I clini ...... onization factor antigen CFA/I
@ast
Construction and phase I clini ...... onization factor antigen CFA/I
@en
Construction and phase I clini ...... onization factor antigen CFA/I
@nl
prefLabel
Construction and phase I clini ...... onization factor antigen CFA/I
@ast
Construction and phase I clini ...... onization factor antigen CFA/I
@en
Construction and phase I clini ...... onization factor antigen CFA/I
@nl
P2093
P2860
P1476
Construction and phase I clini ...... onization factor antigen CFA/I
@en
P2093
Alexandra Daley
Arthur K Turner
Cornelia Gewert
Gabriella Casula
Jonathan C Stephens
Judith Greenwood
Juliet C Beavis
Michael J Darsley
Nicola Thomas
Paul Kelly
P2860
P304
P356
10.1128/IAI.74.2.1062-1071.2006
P407
P50
P577
2006-02-01T00:00:00Z